vs

Side-by-side financial comparison of AETHLON MEDICAL INC (AEMD) and Stevanato Group S.p.A. (STVN). Click either name above to swap in a different company.

Aethlon Medical Inc. is a clinical-stage medical technology firm that develops targeted therapeutic devices to address life-threatening health conditions. Its lead product, the Hemopurifier, is designed to remove harmful viruses, cancer-derived exosomes, and other pathogens from the bloodstream. The company primarily operates in the infectious disease and oncology healthcare segments, with main market presence in North America.

Stevanato Group is an Italian multinational company headquartered in Piombino Dese, Padua – Italy. Founded in 1949, it is also active in the glass tube forming technology and inspection systems sector.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AEMD
AEMD
STVN
STVN
Q4 24
$60.0K
Q3 24
$95.1K
Net Profit
AEMD
AEMD
STVN
STVN
Q4 24
$-1.8M
Q3 24
$-2.8M
Operating Margin
AEMD
AEMD
STVN
STVN
Q4 24
-3026.4%
Q3 24
-3050.2%
Net Margin
AEMD
AEMD
STVN
STVN
Q4 24
-2926.4%
Q3 24
-2950.2%
EPS (diluted)
AEMD
AEMD
STVN
STVN
Q4 24
$-10.05
Q3 24
$-16.11

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons